Selleckchem Inc

Bio Active Compounds.

Recent products

Anti-PDGFC / VEGFE

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Tavolixizumab (Anti-TNFRSF4 / OX40 / CD134)

Price range: £303.00 through £2,432.00 / 424.203,404.80 Standard

Vesencumab (Anti-NRP1 / VEGF165R / CD304)

Price range: £384.00 through £3,415.00 / 537.604,781.00 Standard

Brontictuzumab (Anti-NOTCH1)

Price range: £384.00 through £3,415.00 / 537.604,781.00 Standard

Ozanezumab (Anti-RTN4 / NOGO)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Tanezumab (Anti-NGF / bNGF)

Price range: £303.00 through £2,432.00 / 424.203,404.80 Standard

Fulranumab (Anti-NGF / bNGF)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Trevogrumab (Anti-GDF8 / Myostatin)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Landogrozumab (Anti-GDF8 / Myostatin)

Price range: £303.00 through £2,432.00 / 424.203,404.80 Standard

Sofituzumab (Anti-MUC16)

Price range: £466.00 through £4,152.00 / 652.405,812.80 Standard

Oregovomab (Anti-MUC16)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Anetumab (Anti-Mesothelin)

Price range: £303.00 through £2,432.00 / 424.203,404.80 Standard

Anti-MAGEA3

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Anti-Lewis Y (MB 311)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Anti-CXCL8 / IL-8 (HuMax-IL8)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Lusvertikimab (Anti-IL-7Ra / CD127)

Price range: £303.00 through £2,432.00 / 424.203,404.80 Standard

1 676 677 678 705